![William P. Tew](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William P. Tew
Directeur Général chez
GlycoMira Therapeutics, Inc.
Profil
William P.
Tew is the founder of Cangene bioPharma LLC, which was founded in 1980.
He held the titles of Chairman & Chief Executive Officer from 1980 to 1999.
Currently, he is the Chief Executive Officer of GlycoMira Therapeutics, Inc. Dr. Tew's former positions include President & Chief Executive Officer of Glycosan BioSystems, Inc., Director of Carterra, Inc., Chief Commercial Officer of Lineage Cell Therapeutics, Inc. from 2011 to 2015, Advisory Board Member of NMGF Management LLC, and Vice President-Business Development of OrthoCyte Corp.
Dr. Tew received a doctorate degree from the University of Idaho in 1976.
Postes actifs de William P. Tew
| Sociétés | Poste | Début |
|---|---|---|
GlycoMira Therapeutics, Inc.
 GlycoMira Therapeutics, Inc. BiotechnologyHealth Technology Develops glycosaminoglycan-based therapeutics | Directeur Général | - |
Anciens postes connus de William P. Tew
| Sociétés | Poste | Fin |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2015 |
Cangene bioPharma LLC
 Cangene bioPharma LLC BiotechnologyHealth Technology Provides commercial drug production services | Fondateur | 01/01/1999 |
OrthoCyte Corp.
 OrthoCyte Corp. Pharmaceuticals: MajorHealth Technology Develops cellular therapeutics for orthopedic repair diseases and injuries | Corporate Officer/Principal | - |
Glycosan BioSystems, Inc.
 Glycosan BioSystems, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets formulations of a hyaluronan-based synthetic extracellular matrix | President | - |
Carterra, Inc.
 Carterra, Inc. Medical SpecialtiesHealth Technology Develops novel microarray deposition technologies and biotechnology solutions | Directeur/Membre du Conseil | - |
Formation de William P. Tew
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Cangene bioPharma LLC
Cangene bioPharma LLC BiotechnologyHealth Technology Provides commercial drug production services | Health Technology |
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Carterra, Inc.
Carterra, Inc. Medical SpecialtiesHealth Technology Develops novel microarray deposition technologies and biotechnology solutions | Health Technology |
Glycosan BioSystems, Inc.
Glycosan BioSystems, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets formulations of a hyaluronan-based synthetic extracellular matrix | Health Technology |
University of Idaho
 University of Idaho Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NMGF Management LLC
 NMGF Management LLC Investment ManagersFinance New Markets Venture Partners invests in companies located in the United States with an enterprise value of USD 3.3 billion. The firm targets companies operating in the fields of transformative education, workforce, information technology and business services. It provides financing for early and growth stage capital requirements. | Finance |
OrthoCyte Corp.
OrthoCyte Corp. Pharmaceuticals: MajorHealth Technology Develops cellular therapeutics for orthopedic repair diseases and injuries | Health Technology |
GlycoMira Therapeutics, Inc.
GlycoMira Therapeutics, Inc. BiotechnologyHealth Technology Develops glycosaminoglycan-based therapeutics | Health Technology |
